CONTACT US
In 2023, in partnership with our generous donors and supporters, nine research grants have been awarded totaling approximately $6.7 million. Overall, PanCAN invested more than $34 million in research this year, which includes our grants program as well as our large-scale scientific and clinical initiatives.
Awarded through a rigorous peer-review process, the PanCAN 2023 Research Grants Program includes funding for projects to find an early detection strategy and accelerate treatments for pancreatic cancer patients.
Please join us in welcoming this year’s grantees:
2023 Pancreatic Cancer Action Network Cancer Informatics and Data Science Research FellowshipBasil Bakir, MD, PhD
Columbia University
Predictive Biomarkers For Chemotherapy Through Master Regulator Analysis
2023 Pancreatic Cancer Action Network Catalyst Research Award funded in memory of Daniel J. KobasicWansu Chen, PhD
Kaiser Permanente Southern California Department of Research & Evaluation
Recent-onset Hyperglycemia and the Risk of Pancreatic Cancer: An Enhancement of the ENDPAC Model
2023 Pancreatic Cancer Action Network Fellowship, funded by the Francois Wallace Monahan Fund in loving memory of Michael InselGuillaume Cognet, PhD
University of Chicago
Glycine availability in the PDAC tumor microenvironment as a driver of chemoresistance
2023 Pancreatic Cancer Action Network Fellowship, funded by the Francois Wallace Monahan Fund in loving memory of Michael InselJulien Dilly, MS
Dana-Farber Cancer Institute
Understanding mechanisms of response and resistance to RAS-pathway inhibition in pancreatic cancer
2023 Pancreatic Cancer Action Network Career Development Award in memory of Llewellyn Bixby IV, through a gift made by his familyWilliam Freed-Pastor, MD, PhD
Dana-Farber Cancer Institute
Immunopeptidomics to Accelerate Immunotherapies in Pancreas Cancer
2023 Pancreatic Cancer Action Network Career Development Award, funded by an anonymous donorArjun Gupta, MD
University of Minnesota Medical School
Medication-related Financial Burdens in Older Adults with Pancreatic Cancer
2023 Pancreatic Cancer Action Network Therapeutic Accelerator AwardSupported in memory of Skip Viragh
Thomas Heineman, MD, PhD
Oncolytics Biotech, Inc.
Pelareorep + mFOLFIRINOX +/- atezolizumab for the treatment of 1L mPDAC
2023 Pancreatic Cancer Action Network Career Development Award funded by Rick Star in Memory of Janet Ranta StarWilliam L. Hwang, MD, PhD
Massachusetts General Hospital
Mechanisms of Cancer-Nerve Dynamics in Pancreatic Cancer
2023 Pancreatic Cancer Action Network Career Development AwardIvana Peran, PhD
Georgetown University’s Lombardi Comprehensive Cancer Center
Role of Stromal Cadherin 11 in Chemotherapy Response in Pancreatic Cancer
